There is frustration with the pace of Ireland's COVID-19 vaccine rollout, particularly compared to other EU countries.
Kingston Mills, professor of experimental immunology at Trinity College Dublin, suggested in an Irish Times article over the weekend that we should consider not vaccinating people who have recovered from COVID-19 while vaccine stocks are limited.
This is because these people can be considered to have antibodies.
Kingston joined us on The Last Word to discuss the issue.
